Diabetes, Heart and Cardiovascular Diseases News Chronicle. Diabetes, Cardiovascular and Heart Diseases. Article 106
Published on January 4, 2017 at 01:30 PM


 



Risks With Chronic Gum Disease

Researchers say erectile dysfunction (ED) is common in men with a chronic bacterial infection in gum (called periodontitis). Periodontitis in adults causes tooth loss and increases the risk of cardiovascular disease, stroke, hardening of arteries and inflammation. Researchers analyzed 213,000 participants data, aged between 20 to 80 from five studies done between 2009 and 2014. Studies found that

A study done in 2003 says erectile dysfunction can be improved by treating periodontitis. As chronic periodontitis was linked to several chronic diseases including erectile dysfunction (ED), patients should focus on cleaning interdental parts to reduce dental plaque formation and gingival inflammation. Senior author of the study is Dr. Zhigang Zhao, Guangzhou Medical University, China and the study findings were published in International Journal of Impotence Research.



       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below):

Also related to this story
1. Study Links Periodontal Gum Disease to Heart Disease And Strokes
2. Chameleon Wearable Fitness Tracker From Adidas
3. Wearable Belt Type Medical Device To Treat Diabetes In Obese Individuals
4. Portable Device To Check Diabetes With Exhale Of Acetone Chemical
5. Personalized Diet And Fitness Device & App From STYR Labs

Erectile dysfunction : Unable to develop or sustaining hardness or firm erection of the penis when nerves in penis receive signals from the brain during sexual activity or arousal is called erectile dysfunction or impotence. Corpora cavernosa is a part of the penis that contains small blood vessels and works like a sponge. Developing and maintaining erection happens when blood enters and retains within this spongy corpora cavernosa. Erectile dysfunction (ED) problem arises if something blocks brain signals or flow of blood to corpora cavernosa. Symptoms of Erectile dysfunction (ED) are

  • Reduced thinking about sex
  • Unable to achieve penis hardness
  • Not sustaining hardness of penis

Causes for erectile dysfunction (ED) are

  • Parkinson's disease
  • Diabetes
  • Cardiovascular disease
  • Drug side effects
  • Neurological problems such as trauma
  • Heart disease
  • Obesity or overweight
  • Multiple sclerosis
  • Hormone problems
  • Smoking habit
  • Enlarged prostate gland
  • Excess alcohol consumption
  • Cavernosal disorders
  • Aging
  • Kidney failure
  • Narrowing blood vessels
  • Psychological conditions such as depression, stress, performance anxiety etc
  • The shape of cycle seat put pressure on the perineum and damages its performance (a part of the penis which is vital for sexual arousal)

Treatments for Erectile dysfunction (ED) are

  • Medications such as Cialis, Viagra or Levitra but patients should know the side effects. An individual with excess blood sugar levels and stroke should not use medications
  • Implants
  • Surgery
  • Vacuum pumps
  • Lifestyle changes such as stopping alcohol consumption, exercise and stopping the smoking habit
  • Zinc supplements
  • Studies show daily consumption of two to three cups of coffee can reduce the risk of Erectile dysfunction (ED)

 



FDA Clears Xultophy And Soliqua

Both Xultophy (made by Novo Nordisk, Denmark) and Soliqua (made by Sanofi, France) are combination drugs approved by FDA for the treatment of type 2 diabetes. They combine long-lasting insulin with GLP-1 to stimulate insulin production in the pancreas and to improve glycemic control. The European Commission has approved Xultophy during 2014 which contains GLP-1 agonist Victoza and Tresiba insulin drug. Similarly, Soliqua contains GLP-1 Lyxumia and Lantus insulin drug. Both these drugs are once in a day injections. Soliqua drug may be launched during January 2017 and Xultophy during the middle of 2017.



       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below):

Also related to this story
1. FDA Approval Of CONTOUR ® NEXT ONE
2. FDA Approves Medtronic Artificial Pancreas MiniMed 670G
3. Hypoglycemia & HbA1c. Approval Of Diabetes Drug Xultophy Liraglutide From Novo Nordisk
4. Wearable Technology For Elder Care
5. About Meizus H1 Wearable Device

 



No Risks With Higher Insulin Doses

A study done by researchers from School of Pharmacy, Memorial University of Newfoundlands, Canada says there is no association between higher insulin medication and increased risk of cardiovascular diseases in type 2 diabetes patients. They assured insulin-using patients and healthcare professionals that there are no major risks associated with the use of insulin. Researchers analyzed 6,072 new insulin drug users with type 2 diabetes aged more than 30 years and using metformin from 2001 to 2012 and came to the following conclusion. Author of the study is John-Michael Gamble, PhD.



       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below):

Also related to this story
1. Insulin Pens
2. Insulin Usage May Trigger ESRD
3. Wearable Devices Market
4. Wearable Device To Alleviate Stress and Anxiety
5. About Esysta device

 



Categories

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

 

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.